NM_006440.5:c.375-62C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006440.5(TXNRD2):​c.375-62C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.603 in 1,383,662 control chromosomes in the GnomAD database, including 257,704 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 33372 hom., cov: 33)
Exomes 𝑓: 0.60 ( 224332 hom. )

Consequence

TXNRD2
NM_006440.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.520

Publications

16 publications found
Variant links:
Genes affected
TXNRD2 (HGNC:18155): (thioredoxin reductase 2) The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes a mitochondrial form important for scavenging reactive oxygen species in mitochondria. It functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants encoding different isoforms, including a few localized in the cytosol and some lacking the C-terminal Sec residue, have been found for this gene. [provided by RefSeq, Jun 2017]
TXNRD2 Gene-Disease associations (from GenCC):
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial glucocorticoid deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • glucocorticoid deficiency 5
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 22-19918279-G-A is Benign according to our data. Variant chr22-19918279-G-A is described in ClinVar as Benign. ClinVar VariationId is 678090.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.902 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TXNRD2NM_006440.5 linkc.375-62C>T intron_variant Intron 4 of 17 ENST00000400521.7 NP_006431.2 Q9NNW7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TXNRD2ENST00000400521.7 linkc.375-62C>T intron_variant Intron 4 of 17 1 NM_006440.5 ENSP00000383365.1 Q9NNW7-1

Frequencies

GnomAD3 genomes
AF:
0.652
AC:
99169
AN:
152046
Hom.:
33309
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.771
Gnomad AMI
AF:
0.533
Gnomad AMR
AF:
0.708
Gnomad ASJ
AF:
0.632
Gnomad EAS
AF:
0.923
Gnomad SAS
AF:
0.735
Gnomad FIN
AF:
0.618
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.550
Gnomad OTH
AF:
0.628
GnomAD4 exome
AF:
0.597
AC:
735214
AN:
1231498
Hom.:
224332
AF XY:
0.599
AC XY:
373742
AN XY:
623594
show subpopulations
African (AFR)
AF:
0.780
AC:
22687
AN:
29086
American (AMR)
AF:
0.772
AC:
33710
AN:
43682
Ashkenazi Jewish (ASJ)
AF:
0.636
AC:
15682
AN:
24644
East Asian (EAS)
AF:
0.912
AC:
35241
AN:
38642
South Asian (SAS)
AF:
0.712
AC:
57862
AN:
81218
European-Finnish (FIN)
AF:
0.617
AC:
31621
AN:
51244
Middle Eastern (MID)
AF:
0.553
AC:
2950
AN:
5334
European-Non Finnish (NFE)
AF:
0.556
AC:
502924
AN:
904740
Other (OTH)
AF:
0.615
AC:
32537
AN:
52908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
14728
29456
44185
58913
73641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13184
26368
39552
52736
65920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.653
AC:
99293
AN:
152164
Hom.:
33372
Cov.:
33
AF XY:
0.660
AC XY:
49071
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.772
AC:
32038
AN:
41522
American (AMR)
AF:
0.708
AC:
10831
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.632
AC:
2196
AN:
3472
East Asian (EAS)
AF:
0.924
AC:
4775
AN:
5170
South Asian (SAS)
AF:
0.736
AC:
3548
AN:
4822
European-Finnish (FIN)
AF:
0.618
AC:
6538
AN:
10582
Middle Eastern (MID)
AF:
0.493
AC:
145
AN:
294
European-Non Finnish (NFE)
AF:
0.550
AC:
37405
AN:
67992
Other (OTH)
AF:
0.631
AC:
1333
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1790
3580
5371
7161
8951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
796
1592
2388
3184
3980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.588
Hom.:
115295
Bravo
AF:
0.665
Asia WGS
AF:
0.804
AC:
2792
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.8
DANN
Benign
0.45
PhyloP100
0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs756661; hg19: chr22-19905802; API